U.S. Food and Drug Administration requirements for toxicity testing of contraceptive products.
D000818:Animals; D003276:Contraceptives, Oral / Q000633:toxicity*; D004285:Dogs; D004341:Drug Evaluation / Q000592:standards*; D004353:Drug Evaluation, Preclinical / Q000592:standards*; D004967:Estrogens / Q000633:toxicity*; D005260:Female; D000882:Haplorhini; D006801:Humans; D007880:Legislation, Drug; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced*; D008656:Mestranol / Q000633:toxicity; D008722:Methods; D009644:Norgestrel / Q000633:toxicity; D011372:Progestins / Q000633:toxicity*; D011453:Prostaglandins / Q000008:administration & dosage; D051381:Rats; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins; D011453:Prostaglandins; D009644:Norgestrel; D008656:Mestranol